• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于乳腺癌生物标志物多色检测的 pH 响应变色纳米粒子。

pH-responsive allochroic nanoparticles for the multicolor detection of breast cancer biomarkers.

机构信息

Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, International Joint Research Center for Intelligent Biosensing Technology and Health, College of Chemistry, Central China Normal University, Wuhan, 430079, PR China.

China Resources & Wisco General Hospital, Wuhan, 430080, PR China.

出版信息

Biosens Bioelectron. 2020 Jan 15;148:111780. doi: 10.1016/j.bios.2019.111780. Epub 2019 Oct 11.

DOI:10.1016/j.bios.2019.111780
PMID:31665670
Abstract

Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) are the three crucial biomarkers for the clinical diagnosis of breast cancer. Sensitive and precise detection of ER, PR, and HER2 is of great significance for the diagnosis of breast cancer. Herein, through a simple solvent-induced self-assembly process, the self-carried allochroic nanoparticles were prepared by using some hydrophobic pH indicator molecules for allochroic NPs-linked immunosorbent assay (named ALISA) of ER, PR, and HER2, respectively. Meanwhile, the introduction of bovine serum albumin (BSA) and antibody (Ab) enhanced the dispersity of the self-assembled nanoparticles as signal tags. Since the ultra-high loading and high-efficiency release of pH indicators, the ALISA exhibitssatisfactory selectivity and sensitivity, which demonstrated the great potential in the early diagnosis and postoperative monitoring of breast cancers. Furthermore, the smartphone was introduced to combine with the ALISA for point-of-care testing, indicating the high feasibility in practical applications.

摘要

雌激素受体 (ER)、孕激素受体 (PR) 和人表皮生长因子受体-2 (HER2) 是乳腺癌临床诊断的三个关键生物标志物。敏感、准确地检测 ER、PR 和 HER2 对乳腺癌的诊断具有重要意义。在此,通过简单的溶剂诱导自组装过程,使用一些疏水性 pH 指示剂分子制备了自携变色纳米粒子,分别用于 ER、PR 和 HER2 的异相 NPs-酶联免疫吸附测定 (ALISA)。同时,牛血清白蛋白 (BSA) 和抗体 (Ab) 的引入增强了自组装纳米粒子作为信号标记物的分散性。由于 pH 指示剂的超高负载量和高效释放,ALISA 表现出令人满意的选择性和灵敏度,这表明其在乳腺癌的早期诊断和术后监测方面具有巨大的潜力。此外,引入智能手机与 ALISA 相结合进行即时检测,表明其在实际应用中具有很高的可行性。

相似文献

1
pH-responsive allochroic nanoparticles for the multicolor detection of breast cancer biomarkers.用于乳腺癌生物标志物多色检测的 pH 响应变色纳米粒子。
Biosens Bioelectron. 2020 Jan 15;148:111780. doi: 10.1016/j.bios.2019.111780. Epub 2019 Oct 11.
2
Histological Grade and Immunohistochemical Biomarkers of Breast Cancer: Correlation to Ultrasound Features.乳腺癌的组织学分级和免疫组化生物标志物:与超声特征的相关性
J Ultrasound Med. 2017 Sep;36(9):1883-1894. doi: 10.1002/jum.14247. Epub 2017 May 27.
3
A pH Indicator-linked Immunosorbent assay following direct amplification strategy for colorimetric detection of protein biomarkers.一种基于 pH 指示剂的免疫吸附分析方法,采用直接扩增策略,用于蛋白质生物标志物的比色检测。
Biosens Bioelectron. 2017 Apr 15;90:1-5. doi: 10.1016/j.bios.2016.11.033. Epub 2016 Nov 15.
4
Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience.在生物标志物和乳腺癌新兴个性化医疗时代,乳腺癌的TNM分期系统是否仍然适用——一家机构的10年经验
Breast J. 2015 Mar-Apr;21(2):147-54. doi: 10.1111/tbj.12367. Epub 2015 Jan 20.
5
A copper based enzyme-free fluorescence ELISA for HER2 detection.一种用于检测HER2的基于铜的无酶荧光酶联免疫吸附测定法。
J Immunol Methods. 2017 Dec;451:78-82. doi: 10.1016/j.jim.2017.09.002. Epub 2017 Sep 14.
6
Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.乳腺癌女性血清和组织样本中HER2/neu癌蛋白的评估
Indian J Med Res. 2016 May;143(Supplement):S52-S58. doi: 10.4103/0971-5916.191769.
7
A sandwich-type electrochemical immunosensor based on in situ silver deposition for determination of serum level of HER2 in breast cancer patients.基于原位银沉积的三明治型电化学免疫传感器用于测定乳腺癌患者血清中 HER2 水平。
Biosens Bioelectron. 2018 Apr 30;103:54-61. doi: 10.1016/j.bios.2017.12.022. Epub 2017 Dec 20.
8
A Multicolor Immunosensor for Sensitive Visual Detection of Breast Cancer Biomarker Based on Sensitive NADH-Ascorbic-Acid-Mediated Growth of Gold Nanobipyramids.基于敏感的 NADH-抗坏血酸介导的金纳米双子塔生长的用于乳腺癌生物标志物灵敏可视化检测的多色免疫传感器。
Anal Chem. 2020 Jan 7;92(1):1534-1540. doi: 10.1021/acs.analchem.9b04828. Epub 2019 Dec 16.
9
IL-6, IL-8 and TNF-α levels correlate with disease stage in breast cancer patients.白细胞介素-6、白细胞介素-8和肿瘤坏死因子-α水平与乳腺癌患者的疾病分期相关。
Adv Clin Exp Med. 2017 May-Jun;26(3):421-426. doi: 10.17219/acem/62120.
10
Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.雌激素受体、孕激素受体及人表皮生长因子受体2在乳腺癌细针穿刺抽吸细胞块及配对组织学标本中的表达:一项大型回顾性研究。
Cancer Cytopathol. 2016 Nov;124(11):828-835. doi: 10.1002/cncy.21745. Epub 2016 Jun 17.

引用本文的文献

1
Nanolabels Prepared by the Entrapment or Self-Assembly of Signaling Molecules for Colorimetric and Fluorescent Immunoassays.通过信号分子包封或自组装制备的用于比色和荧光免疫测定的纳米标签。
Biosensors (Basel). 2024 Dec 6;14(12):597. doi: 10.3390/bios14120597.
2
Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges.基于生物聚合物的癌症治疗纳米医学:机遇与挑战。
Int J Nanomedicine. 2024 Jul 22;19:7415-7471. doi: 10.2147/IJN.S460047. eCollection 2024.
3
Advancements in Biosensors Based on the Assembles of Small Organic Molecules and Peptides.
基于小分子有机分子和肽组装的生物传感器的进展。
Biosensors (Basel). 2023 Jul 29;13(8):773. doi: 10.3390/bios13080773.
4
Colorimetric Systems for the Detection of Bacterial Contamination: Strategy and Applications.比色系统用于检测细菌污染:策略与应用。
Biosensors (Basel). 2022 Jul 16;12(7):532. doi: 10.3390/bios12070532.
5
Nano-Based Theranostic Platforms for Breast Cancer: A Review of Latest Advancements.用于乳腺癌的纳米基诊疗平台:最新进展综述
Bioengineering (Basel). 2022 Jul 15;9(7):320. doi: 10.3390/bioengineering9070320.